Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-018549)

Filing Details

Accession Number:: 0001181431-13-018549
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-25 15:17:25
Reporting Period:: 2013-03-21

Filing Date:: 2013-03-25
Accepted Time:: 2013-03-25 15:17:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356576	Supernus Pharmaceuticals Inc	SUPN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190558	M John Siebert	C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-03-21	3,000	$5.50	15,188	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Director Stock Option (Right to Buy)	$7.90	2014-02-05	2023-02-05	8,722	8,722	Direct
Common Stock	Director Stock Option (Right to Buy)	$4.24		2021-10-14	6,562	6,562	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-02-05	8,722	8,722	Direct
2021-10-14	6,562	6,562	Direct

Footnotes

25% of the shares subject to the option vested on 10/14/2012, and the remaining shares subject to the option will vest in approximately equal quarterly installments over the following three years.